Unichem Laboratories

₹502.60As of Sun 8 Nov 2026, 12:00 UTC

NSE:UNICHEMLABHealthcare

Country India

PE (Fwd) 12.99

TSR 10Y CAGR 6.63%

Div yield —

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) —

PE TTM 14.02

TSR TTM 6.72%

Mkt cap ₹35.92B

ROIC —

SE Grade™

—

Value

Quality

Moat

—

1Y Price

Reference

₹559

11.20%

(38.26%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

22.02

Revenue₹B

—

12.70

13.43

17.85

21.11

22.02

23.81

14.75%

4.31

Revenue growth%

—

5.76

32.92

18.25

4.31

8.12

12.01

—

50.34

Gross margin%

—

63.10

54.85

55.47

56.33

50.34

50.08

55.47

2.89

Operating margin%

—

(0.86)

(11.58)

(2.03)

6.65

2.89

2.55

(0.86)

11.48

Net margin%

—

2.60

(15.06)

(5.25)

6.51

11.48

10.93

2.60

14.02

P/E ratio (avg)x

—

57.68

—

36.10

14.53

13.62

36.10

—

55.77

EV/EBITx

—

35.38

57.79

58.35

46.58

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

35.85

EPS₹

—

4.68

(28.72)

(13.32)

19.47

35.85

36.90

66.32%

—

84.09

EPS growth%

—

(713.17)

53.64

246.22

84.09

2.93

68.86

—

100

—

Bookvalue per sh₹

—

FCF per share₹

—

Dividend per sh₹

—

4.00

—

Div yield (avg)%

—

1.48

—

1.48

—

Payout ratio%

—

85.47

—

70.53

Shares (diluted)M

—

70.58

70.41

70.62

70.53

◌70.53

(0.02%)

0.13

Buyback yield%

—

0.25

—

(0.31)

0.13

◌—

0.06

—

D/E ratiox

—

35.45

Enterprise value₹B

—

19.07

24.30

28.74

49.64

36.73

35.45

17.81%

—

LT debt₹M

—

Peers (US$379.2M)

Cap (US$)

Aarti Drugs Limited

433.3M

17.80x

Kwality Pharmaceutical…

402.7M

46.67x

Solara Active Pharma…

325.2M

79.25x

Blau Farmacêutica S.A.

379.5M

8.971x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

2.019

(1.638)

Own earn%

—

Sh yield%

0.13

0.06

Owners

Insiders/Inst%

17.56

10.40

Short interest%

—

SBC / revenue%

0.02

Record

10Y

Profitable years

3/5

Revenue growth years

4/4

EPS growth years

3/4

Dividend streakyrs

Op margin range%

−12–7

$1 testx

—

Incr. ROIC%

—

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹22.02B

14.75%

1.00×

Cost of revenue

₹10.94B

23.60%

1.35×

Operating expenses

₹10.45B

6.50%

0.74×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m